bupivacaine has been researched along with alphaxalone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedoya, M; Decher, N; González, W; Kiper, AK; Ramírez, D; Rinné, S | 1 |
| Meadows, HJ; Randall, AD | 1 |
| Aguiar, J; Chebroux, A; Leece, EA; Martinez-Taboada, F | 1 |
1 review(s) available for bupivacaine and alphaxalone
| Article | Year |
|---|---|
TASK Channels Pharmacology: New Challenges in Drug Design.
Topics: Animals; Drug Design; Drug Discovery; Humans; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain | 2019 |
1 trial(s) available for bupivacaine and alphaxalone
| Article | Year |
|---|---|
Analgesic effects of maxillary and inferior alveolar nerve blocks in cats undergoing dental extractions.
Topics: Anesthesia, Dental; Animals; Bupivacaine; Buprenorphine; Cat Diseases; Cats; Isoflurane; Lidocaine; Medetomidine; Nerve Block; Pain, Postoperative; Preanesthetic Medication; Pregnanediones; Tooth Extraction | 2015 |
1 other study(ies) available for bupivacaine and alphaxalone
| Article | Year |
|---|---|
Functional characterisation of human TASK-3, an acid-sensitive two-pore domain potassium channel.
Topics: 1-Methyl-3-isobutylxanthine; Acids; Animals; Barium Compounds; Bupivacaine; Cell Line; Cesium; Chlorides; Colforsin; Dose-Response Relationship, Drug; Female; Gene Expression; Glyburide; Halothane; Humans; Kinetics; Membrane Potentials; Oocytes; Potassium; Potassium Channels; Potassium Channels, Tandem Pore Domain; Pregnanediones; Tetradecanoylphorbol Acetate; Tetraethylammonium; Time Factors; Xenopus | 2001 |